Calistair non-thermal catalysis air purification technology for B2C applications

Technology
In development
Company

Calistair's proprietary non-thermal catalysis technology uses advanced materials and UV-C activation to mineralize airborne VOCs, viruses, and pollutants. Seeking validation in compact B2C-format air purifiers through standardized in-house testbeds equipped with PTR-MS measurement capabilities.

Overview

Calistair has developed a proprietary non-thermal catalysis technology for air purification that mineralizes volatile organic compounds (VOCs), microbiological contaminants, and chemical pollutants without producing toxic by-products such as ozone. The technology combines honeycomb structures impregnated with advanced materials—including zeolites and metal-organic frameworks (MOFs)—with UV-C activation to generate hydroxyl and superoxide radicals that destroy airborne contaminants on contact.

The company is now focused on validating this technology for B2C (business-to-consumer) applications, specifically compact air purification units handling airflows up to 500–600 m³/h. Previous third-party testing has demonstrated strong efficacy across a range of VOCs and microbiological contaminants, including coronavirus HCoV-E229, E. coli, and S. aureus, but results have been inconsistent due to varying testing conditions across different laboratories. Calistair aims to establish a standardized, reproducible methodology through dedicated in-house testbeds.

Technical specifications

Core technology components:

  • Proprietary non-thermal catalysis method integrated into modular reactors
  • Honeycomb support structures impregnated with zeolites and metal-organic frameworks (MOFs)
  • UV-C activation system generating hydroxyl and superoxide radicals
  • No ozone or toxic by-products produced during operation
  • Scalable design suitable for retrofitting into ventilation systems or standalone air purifiers

Validation objectives:

  • Two dedicated testbeds for testing gaseous and microbiological pollutants
  • Single-pass and recycling air treatment configurations
  • Compatibility with compact B2C units under 600 m³
  • Standardized protocols to generate objective, reproducible efficacy and innocuity data
  • Capability to measure performance across several dozen pollutants at varied airflow rates

Current gap: The critical PTR-MS (Proton Transfer Reaction Mass Spectrometry) measurement system needed for precise VOC analysis has not yet been acquired due to its high cost. With this equipment, Calistair estimates full validation testing could commence within six months.

Technology readiness level

The technology has been validated through multiple independent third-party laboratories and institutes, demonstrating positive efficacy on a wide range of VOCs and gaseous pollutants. Microbiological testing has shown the technology can exceed one-log decontamination per airflow pass for pathogens including coronavirus HCoV-E229, E. coli, and S. aureus. However, the heterogeneous nature of existing test data limits the ability to present standardized, comparable results. Calistair has defined testing methodologies and protocols, and most equipment has been acquired for the in-house testbeds. The technology is currently at a stage where standardized B2C validation is the remaining milestone before broader consumer market deployment.


About Calistair

Founded in 2014, Calistair is a material science and chemical technology company specializing in innovative air purification and contaminant capture. Its core technology, the Calistair Technology, utilizes a proprietary non-thermal catalysis method integrated into modular reactors. These reactors combine honeycomb structures impregnated with advanced materials—such as zeolites and metal-organic frameworks (MOFs)—with UV-C activation. This process generates hydroxyl and superoxide radicals that effectively mineralize and destroy airborne biocontaminants, volatile organic compounds (VOCs), chemical pollutants, and viruses, including coronaviruses, without producing toxic by-products like ozone. The technology is designed for scalability and high-velocity airflow, allowing it to be retrofitted into ventilation systems or utilized in dedicated air purification units.

Calistair's solutions are engineered to improve safety standards in environments ranging from hospitals, laboratories, and cleanrooms to industrial buildings and public spaces. The company serves a global client base, including medical facilities requiring high particulate cleanliness standards and industrial sectors focused on emission reduction and gas purification. Since its inception, the company has received recognition for its contributions to public safety, notably during the COVID-19 pandemic, and continues to advance its material science research for applications in energy storage, defense, and pharmaceutical sectors. Headquartered in France, Calistair maintains integrated R&D and manufacturing capabilities to support the implementation of its air decontamination technology across diverse industrial and medical applications.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.